The high consistency of calculated lg10(fold change) values of both differential gene expression analysis and the robust expression level in cell lines suggest linear TRAM1 RNA species as potential candidates for tumor markers with reduced expression in higher cancer stages. The gene discussed is TRAM1; the disease is neoplasm.